The headlines are scattered with the aftermath and debated value of the social influencer. Kim Kardashian made network news headlines with the story where she and the manufacturer of Diclegis, a morning sickness drug, were warned by the FDA for Kim’s glowing one-sided promotion of the drug with blatant disregard for the minefield that is pharmaceutical advertising.
Read more: http://ift.tt/1KlvWr9
No comments:
Post a Comment